Finemedix Co., Ltd. (KOSDAQ:387570)
South Korea flag South Korea · Delayed Price · Currency is KRW
6,130.00
+30.00 (0.49%)
At close: Jun 4, 2026

Finemedix Ratios and Metrics

Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
32,74540,72878,252---
Market Cap Growth
-22.49%-47.95%----
Enterprise Value
29,87038,43580,482---
Last Close Price
6030.007500.0014410.00---
PS Ratio
3.324.287.86---
PB Ratio
1.792.143.77---
P/TBV Ratio
1.802.163.79---
P/OCF Ratio
--458.48---
EV/Sales Ratio
3.034.048.08---
EV/EBITDA Ratio
--93.59---
Debt / Equity Ratio
0.180.210.190.340.480.66
Debt / EBITDA Ratio
--4.572.3318.71-
Debt / FCF Ratio
---4.11--
Net Debt / Equity Ratio
-0.16-0.14-0.310.130.260.41
Net Debt / EBITDA Ratio
1.901.71-7.540.8810.04-3.31
Net Debt / FCF Ratio
1.440.7915.271.55-1.41-5.03
Asset Turnover
0.400.360.440.550.420.35
Inventory Turnover
1.201.241.471.901.912.60
Quick Ratio
3.623.584.261.691.210.99
Current Ratio
5.785.305.372.481.851.47
Return on Equity (ROE)
-9.34%-9.44%-0.14%9.72%2.15%-14.49%
Return on Assets (ROA)
-6.25%-6.15%-0.37%2.94%-2.13%-7.00%
Return on Invested Capital (ROIC)
-15.66%-16.90%-0.95%6.06%-3.63%-16.03%
Return on Capital Employed (ROCE)
-11.20%-11.30%-0.60%5.70%-4.50%-14.40%
Earnings Yield
-5.45%-4.61%-0.03%---
FCF Yield
-6.10%-8.56%-0.54%---
Buyback Yield / Dilution
-7.27%-12.41%-5.42%-1.75%-38.53%-9.53%